How to Buy Bridgebio Oncology Therapeutics Stock

Bridgebio Oncology Therapeutics Inc

BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule therapeutics targeting RAS and PI3Kα malignancies, which are prevalent oncogenes in human tumors.

Bridgebio Oncology Therapeutics stock last closed at $8.94, down 5.4% from the previous day, and has decreased 13.29% in one year. It has overperformed other stocks in the Biotechnology industry by 0.4 percentage points. Bridgebio Oncology Therapeutics stock is currently +5.18% from its 52-week low of $8.50, and -28.48% from its 52-week high of $12.50.

There are currently 61.1M BBOT shares outstanding. The market cap of BBOT is $546.23M. In the past 24 hours, 244,000 BBOT shares were traded.

How to Buy Bridgebio Oncology Therapeutics Stock

Wondering how to invest in Bridgebio Oncology Therapeutics stock? Here's how.

  1. Choose where to buy Bridgebio Oncology Therapeutics stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you choose where to buy Bridgebio Oncology Therapeutics stock.
  2. Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Fund your brokerage account: Pick your payment method and add your details.
  4. Research Bridgebio Oncology Therapeutics stock: The Bridgebio Oncology Therapeutics ticker symbol is BBOT. Is Bridgebio Oncology Therapeutics stock a good investment? Should you buy shares of BBOT? How do BBOT's underlying business fundamentals look? Do top analysts think Bridgebio Oncology Therapeutics is a good buy? Why has BBOT's stock price moved recently? (Hint: Our stock research tools can help you decide if BBOT is a good stock to buy).
  5. Place your BBOT purchase: Decide if you will purchase BBOT shares at the current market price or use a limit order to purchase BBOT shares at a given price.
  6. Get the latest news on your investment in BBOT: Create a watchlist to get live updates on your new investment in Bridgebio Oncology Therapeutics shares.

Step 1: Choose where to buy Bridgebio Oncology Therapeutics stock

You need an online brokerage account to access the NASDAQ market and buy BBOT shares.

A brokerage account allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our experience, eToro is the best stock brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to world financial markets: From Technology to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've picked your brokerage, the next step is to fill out some personal info so you can buy BBOT stock today.

How to Start a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to create your new brokerage account.
  1. Submit your application by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you've created your account on mobile trading apps, your next step is to transfer the money for your investment:

Check out this video walkthrough if you need help depositing money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Bridgebio Oncology Therapeutics stock

After you have selected the best place to buy Bridgebio Oncology Therapeutics stock, it's absolutely critical to evaluate their stock prior to investing, so you can understand the risk and opportunity.

Bridgebio Oncology Therapeutics Numbers

BBOT Price
$8.94
1w %
1.13%
1y %
-13.29%
5y %
N/A
P/E
-0.02x
P/B
-2.4x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$106.51M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$546.23M
Next Earnings
Sep 3, 2025
Next Dividend
N/A

Bridgebio Oncology Therapeutics Due Diligence Checks

WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis quickly.

You can see all of the due diligence checks on BBOT's stock page.

Is BBOT stock properly valued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge BBOT's fair value.

You can access more valuation research on BBOT's stock here.

A quick look at BBOT Financials

Passed Financial Due Diligence Checks:

  • There are more short-term assets than short-term liabilities on the BBOT balance sheet.
  • There are more short-term assets than long-term liabilities on the BBOT balance sheet.
  • BBOT has $131.53M in cash and short term investments. This is enough to cover its annual cash burn of $97.71M.
  • BBOT has cash burn of 97713902. It has sufficient cash and short-term investments to cover this for at least one year.

Failed Financial Due Diligence Checks:

  • Total BBOT debt is still negative.
  • BBOT debt to equity ratio of -0.13 is negative.

You can dig deeper into what analysts are saying on the Bridgebio Oncology Therapeutics stock forecast page.

BBOT Trading Indicators

SMA10
9.74
SMA20
9.8
SMA50
10.32
SMA100
10.58
SMA200
10.63
MACD
-0.31
MACD Signal
-0.22
MACD Histogram
-0.09
RSI
40.57
Stochastic %K
13.95
Stochastic %D
18.48
StochRSI %K
21.53
StochRSI %D
24.78

What are BBOT executives and large shareholders up to?

Over the last year, insiders at BBOT have bought more shares than they have sold.

Bihua Chen, Director of BBOT, was the latest BBOT insider to buy. They bought $8,150,235.63 worth of BBOT shares on Aug 11, 2025.

Get more info about who owns BBOT shares here.

Does BBOT stock generate passive income?

No, Bridgebio Oncology Therapeutics doesn't provide an income stream by paying out dividends.

What others are saying about BBOT

One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other traders have to say.

Step 5: Place your BBOT purchase

There are two main types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are usually fine.
  • Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
    If you want to be sure you're buying or selling at a given price, place a limit order.

Click the Open button and eToro will execute the order.

If you want additional assistance buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Get the latest news on your investment in BBOT

Now that you own some shares in BBOT, you'll want to keep up with your investment.

Start a watchlist to track the most important metrics related to your BBOT stock.

BBOT Feed

How to Buy Stock in Bridgebio Oncology Therapeutics

To summarize, here are the 6 steps to buy Bridgebio Oncology Therapeutics stock:

  1. Choose where to buy Bridgebio Oncology Therapeutics stock
  2. Create a brokerage account
  3. Fund your brokerage account
  4. Research Bridgebio Oncology Therapeutics stock
  5. Place your BBOT purchase
  6. Get the latest news on your investment in BBOT

If you require a place to buy stocks, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get the latest scoop on your investment in Bridgebio Oncology Therapeutics, hit the button below to create your watchlist.

NASDAQ: BBOT
$8.94-0.51 (-5.4%)
Updated Aug 29, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: BBOT
$8.94-0.51 (-5.4%)
Updated Aug 29, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Bridgebio Oncology Therapeutics share?

As of Aug 29, 2025, it costs $8.94 to buy one share of Bridgebio Oncology Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $4, you can buy 0.447 shares of BBOT.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

What is the best way to buy Bridgebio Oncology Therapeutics stock?

One way to place an order for Bridgebio Oncology Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.